NBE-Therapeutics Company

NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors. NBE-Therapeutics GmbH engages in the development of antibody drug conjugates for the therapy of cancer.

Technology: Prevention
Industry: P3 Medicine
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 2012
Employees Number: Undisclosed
Funding Status: Early Stage Venture

Visit Website
Register and Claim Ownership